Editorial: Are We in Need for Novel Therapeutics in Anxiety Disorders? (Thematic Issue: Non-Antidepressant Long Term Treatment of Anxiety Disorders)

Publisher： Bentham Science Publishers

E-ISSN： 2212-3938|10|2|84-85

ISSN： 1574-8847

Source： Current Clinical Pharmacology, Vol.10, Iss.2, 2015-01, pp. : 84-85

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Non-Antidepressant Treatment of Social Anxiety Disorder: A Review

By  

Current Clinical Pharmacology, Vol. 10, Iss. 2, 2015-01 ,pp. : 126-130

Bentham Science Publishers

Access to resources Recommend Favorite

Non-Antidepressant Treatment of Generalized Anxiety Disorder

By  

Current Clinical Pharmacology, Vol. 10, Iss. 2, 2015-01 ,pp. : 86-96

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial (Thematic Issue: New Therapeutic Options for Anxiety and Mood Disorders)

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 13, Iss. 6, 2014-08 ,pp. : 927-929

Bentham Science Publishers

Access to resources Recommend Favorite

The clinical decision in long-term treatment of anxiety disorders with benzodiazepines

By Pancheri P.   Biondi M.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 248-248

Elsevier

Access to resources Recommend Favorite

Quetiapine: novel uses in the treatment of depressive and anxiety disorders

By Ravindran Arun V   Al-Subaie Abdullah   Abraham Gebrehiwot  

Expert Opinion on Investigational Drugs, Vol. 19, Iss. 10, 2010-10 ,pp. : 1187-1204

Informa Healthcare

Access to resources Recommend Favorite